Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.
Astuko FujiharaTsuyoshi IwataAliasger ShakirAlessandro TafuriGiovanni E CacciamaniKaranvir GillAkbar AshrafiOsamu UkimuraMihir M DesaiVinay DuddalwarMariana S SternManju AronSuzanne L PalmerInderbir S GillAndre Luis AbreuPublished in: BJU international (2020)
On surveillance mpMRI, PI-RADS ≥3 was associated with increased risk of PCa reclassification. Surveillance biopsy based only on MRI progression may avoid a large number of biopsies at the cost of missing many PCa reclassifications.